U.S. flag

An official website of the United States government

NM_001360.3(DHCR7):c.521T>C (p.Phe174Ser) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001797780.1

Allele description [Variation Report for NM_001360.3(DHCR7):c.521T>C (p.Phe174Ser)]

NM_001360.3(DHCR7):c.521T>C (p.Phe174Ser)

Gene:
DHCR7:7-dehydrocholesterol reductase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.4
Genomic location:
Preferred name:
NM_001360.3(DHCR7):c.521T>C (p.Phe174Ser)
HGVS:
  • NC_000011.10:g.71441332A>G
  • NG_012655.2:g.12100T>C
  • NM_001163817.2:c.521T>C
  • NM_001360.3:c.521T>CMANE SELECT
  • NP_001157289.1:p.Phe174Ser
  • NP_001351.2:p.Phe174Ser
  • NP_001351.2:p.Phe174Ser
  • LRG_340t1:c.521T>C
  • LRG_340:g.12100T>C
  • LRG_340p1:p.Phe174Ser
  • NC_000011.9:g.71152378A>G
  • NM_001360.2:c.521T>C
Protein change:
F174S
Links:
dbSNP: rs769218623
NCBI 1000 Genomes Browser:
rs769218623
Molecular consequence:
  • NM_001163817.2:c.521T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001360.3:c.521T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002041633Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 17, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.

Tucci A, Ronzoni L, Arduino C, Salmin P, Esposito S, Milani D.

BMC Med Genet. 2016 Mar 11;17:22. doi: 10.1186/s12881-016-0287-1.

PubMed [citation]
PMID:
26969503
PMCID:
PMC4788854

Mutational spectrum of Smith-Lemli-Opitz syndrome.

Waterham HR, Hennekam RC.

Am J Med Genet C Semin Med Genet. 2012 Nov 15;160C(4):263-84. doi: 10.1002/ajmg.c.31346. Epub 2012 Oct 5. Review.

PubMed [citation]
PMID:
23042628
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002041633.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: DHCR7 c.521T>C (p.Phe174Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251044 control chromosomes. c.521T>C has been reported in the literature as a compound heterozygous genotype in at-least two individuals affected with Smith-Lemli-Opitz Syndrome, one of whom was reported as having a milder phenotypic presentation (example, Cardoso_2005, Tucci_2016). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024